Back to Search

Center for Gene and Cellular Immunotherapy (CGCI) Registry and Tissue Acquisition for Analysis of Prognostic Factors, Immunology, and Genetic Progression of Patients Treated at CGCI


  • Protocol Number: 201901096
  • Principal Investigator: Singh, Nathan
  • Cancer Types: Gene & Cellular Immunotherapy

For more information on this trial, contact us here:

Phone
800-600-3606
Email
[email protected]